Pengaruh Asam Lemak Omega-3 terhadap Penyakit Kardiovaskular
DOI:
https://doi.org/10.55175/cdk.v49i3.212Keywords:
Asam lemak omega-3, kolesterol, penyakit kardiovaskulerAbstract
Penyakit kardiovaskular merupakan pembunuh utama di seluruh dunia, dua penyakit tersering adalah penyakit jantung koroner dan stroke. Data menunjukkan bahwa asupan makanan yang mengandung tinggi asam lemak omega-3 dapat mengurangi kejadian penyakit kardiovaskular. Asam lemak omega-3 diteliti memiliki efek proteksi terhadap sistem kardiovaskular, memberikan pengaruh baik terhadap tekanan darah, trigliserida, inflamasi, trombosis, dan antiaritmia.
Cardiovascular diseases are the number one global cause of death, the two most common are coronary artery disease and stroke. Data suggests that high omega-3 consumption has a benefit in preventing cardiovascular diseases. Omega-3 is proven to provide cardiovascular protection, improves blood pressure and triglyceride level, controls inflammations and trombosis, and prevents arrythmia.
Downloads
References
WHO | Cardiovascular diseases (CVDs) [Internet]. 2021 [cited 2014 Jul 21]. Available from: http://www.who.int/mediacentre/factsheets/fs317/en/
Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, et al. Obesity and cardiovascular disease: Pathophysiology, evaluation, and effect of weight loss. 2006;113(6):898-918. doi: 10.1161/CIRCULATIONAHA.106.171016.
Lee JH, O’Keefe JH, Lavie CJ, Marchioli R, Harris WS. Omega-3 fatty acids for cardioprotection. Mayo Clin Proc. 2008;83(3):324–32.
Kris-Etherton PM, Harris WS, Appel LJ, American Heart Association. Nutrition Committee. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation. 2002;106(21):2747–57.
Bergheanu SC, Bodde MC, Jukema JW. Pathophysiology and treatment of atherosclerosis: Current view and future perspective on lipoprotein modification treatment. Neth Heart J. 2017;25(4):231–42.
Enayati S, Seifirad S, Amiri P, Abolhalaj M, Amoli MM. Interleukin-1 beta, interferon-gamma, and tumor necrosis factor-alpha gene expression in peripheral blood mononuclear cells of patients with coronary artery disease. ARYA Atheroscler. 2015;11(5):267–74.
Bobryshev YV, Ivanova EA, Chistiakov DA, Nikiforov NG, Orekhov AN. Macrophages and their role in atherosclerosis: Pathophysiology and transcriptome analysis. BioMed Res Int. 2016;2016:1–13.
DeFilippis AP, Sperling LS. Understanding omega-3’s. Am Heart J. 2006;151(3):564–70.
Surette ME. The science behind dietary omega-3 fatty acids. Can Med Assoc J. 2008;178(2):177–80.
Sukrutha SK, Savitha J. Omega-3 fatty acids: A review of its wide range of applications and possible mechanisms of action. Int J Pharm Sci Rev Res. 2014;25:171–7.
de Lorgeril M, Salen P. New insights into the health effects of dietary saturated and omega-6 and omega-3 polyunsaturated fatty acids. BMC Med. 2012;10(1):50.
Ahmed AA, Balogun KA, Bykova NV, Cheema SK. Novel regulatory roles of omega-3 fatty acids in metabolic pathways: A proteomics approach. Nutr Metab. 2014;11(1):6.
Sasikumar S, Eagappan K. Impact of omega-3 fatty acids on blood pressure. Int J Pure App Biosci. 2014;2(2):106–12.
Morton AM, Furtado JD, Lee J, Amerine W, Davidson MH, Sacks FM. The effect of omega-3 carboxylic acids on apolipoprotein CIII−containing lipoproteins in severe hypertriglyceridemia. J Clin Lipidol. 2016;10(6):1442-51.e4.
Kris-Etherton PM, Richter CK, Bowen KJ, Skulas-Ray AC, Jackson KH, Petersen KS, et al. Recent clinical trials shed new light on the cardiovascular benefits of omega-3 fatty acids. Methodist DeBakey Cardiovasc J. 2019;15(3):171–8.
Manson JE, Cook NR, Lee IM, Christen W, Bassuk SS, Mora S, et al. Marine n−3 fatty Acids and prevention of cardiovascular disease and cancer. N Engl J Med.2019;380(1):23–32.
The ASCEND Study Collaborative Group. Effects of n−3 fatty acid supplements in diabetes mellitus. N Engl J Med. 2018;379(16):1540–50.
Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, et al. Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia. N Engl J Med. 2019;380(1):11–22.
Hu Y, Hu FB, Manson JE. Marine omega‐3 supplementation and cardiovascular disease: An updated meta‐analysis of 13 randomized controlled trials involving 127.477 participants. J Am Heart Assoc [Internet]. 2019 Oct [cited 2020 Dec 6];8(19). Available from: https://www.ahajournals.org/doi/10.1161/JAHA.119.01354
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
